Centrallink: Your Global Source for Neuroscience and CNS-Related Biospecimens
Neuroscience research requires biospecimens that reflect the complex biology of the central and peripheral nervous systems. Conditions such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, epilepsy, neuropathies, neuroinflammatory disorders, cerebrovascular diseases, and psychiatric conditions all demand high-quality biospecimens enriched with clinically relevant neurological information. Centrallink supports this need by offering a robust selection of neuroscience-related human biospecimens sourced ethically from global partners.
Our inventory includes cerebrospinal fluid (CSF), serum, plasma, whole blood, tissues, PBMCs, DNA, RNA, and neuro-specific biomaterials associated with a wide range of neurological diseases and CNS conditions. Each biospecimen is accompanied by detailed clinical annotations, diagnostic data, laboratory findings, imaging reports when available, and biomarker information relevant to neurological pathways and brain health.
Clinically Annotated Biospecimens for Neurological and CNS Research
Centrallink provides access to biospecimens that may include key CNS and neurological biomarkers such as beta-amyloid, tau proteins, phosphorylated tau, neurofilament light chain (NfL), GFAP, inflammatory cytokines, neurotransmitter metabolites, and other molecules implicated in neurodegeneration and neuroinflammation.
Samples may also include diagnostic classifications for Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, stroke, epilepsy, traumatic brain injury, neuropathies, and other neurological conditions. This level of detail helps researchers accelerate biomarker validation, therapeutic discovery, and neurological diagnostic development.
Streamlined Procurement for Neuroscience and Brain Research
Centrallink’s digital platform makes it easy to find and procure neuroscience biospecimens with real-time inventory visibility and detailed clinical information. Researchers can filter samples by biomarker levels, diagnosis, disease severity, demographic attributes, and biological matrix to quickly identify the most relevant materials for their work.
For projects requiring specialized CNS biomarkers, rare neurological conditions, longitudinal collections, or matched sample sets, Centrallink offers custom sourcing solutions. Our global network of clinical partners enables us to fulfill highly specific neuroscience research needs with accuracy and reliability.
Advancing Neurodegenerative Research, CNS Diagnostics, and Brain Health
Neuroscience biospecimens play a vital role in understanding the mechanisms behind neurodegeneration, neuroinflammation, cognitive decline, synaptic function, and brain injury. Centrallink supports multi-omics approaches including proteomics, transcriptomics, metabolomics, genomic analysis, and biomarker profiling to advance discoveries in neurological research.
By offering ethically sourced, clinically detailed, and research-ready biospecimens, Centrallink empowers scientists to explore the complexities of the nervous system and accelerate breakthroughs in CNS diagnostics, therapeutic development, and precision neurology.